GHRH and diabetes mellitus: Prof. Andrew Schally and his team of chemists have indeed developed both agonistic and antagonistic molecules of GHRH, which showed promise in regenerative medicine, aiding tissue repair, cardiac function, islet cell survival in diabetes and neuroprotection [5].